FAM
Formidable Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Buy |
1,077
+161
| +18% | +$84.5K | 0.09% | 212 |
|
|
2025
Q1 | $581K | Sell |
916
-3
| -0.3% | -$1.9K | 0.1% | 204 |
|
|
2024
Q4 | $655K | Buy |
919
+131
| +17% | +$93.3K | 0.11% | 184 |
|
|
2024
Q3 | $828K | Sell |
788
-38
| -5% | -$39.9K | 0.13% | 150 |
|
|
2024
Q2 | $868K | Sell |
826
-49
| -6% | -$51.5K | 0.14% | 141 |
|
|
2024
Q1 | $842K | Buy |
875
+91
| +12% | +$87.6K | 0.14% | 152 |
|
|
2023
Q4 | $689K | Sell |
784
-19
| -2% | -$16.7K | 0.14% | 140 |
|
|
2023
Q3 | $661K | Sell |
803
-300
| -27% | -$247K | 0.15% | 145 |
|
|
2023
Q2 | $793K | Buy |
1,103
+184
| +20% | +$132K | 0.17% | 114 |
|
|
2023
Q1 | $755K | Sell |
919
-904
| -50% | -$743K | 0.16% | 114 |
|
|
2022
Q4 | $1.32M | Hold |
1,823
| – | – | 0.3% | 63 |
|
|
2022
Q3 | $1.26M | Buy |
1,823
+43
| +2% | +$29.6K | 0.29% | 65 |
|
|
2022
Q2 | $1.05M | Buy |
1,780
+212
| +14% | +$125K | 0.24% | 81 |
|
|
2022
Q1 | $1.1M | Buy |
1,568
+98
| +7% | +$68.4K | 0.21% | 90 |
|
|
2021
Q4 | $928K | Buy |
1,470
+147
| +11% | +$92.8K | 0.18% | 112 |
|
|
2021
Q3 | $801K | Buy |
+1,323
| New | +$801K | 0.15% | 129 |
|